KR950700403A - 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering) - Google Patents
조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering)Info
- Publication number
- KR950700403A KR950700403A KR1019940703107A KR19940703107A KR950700403A KR 950700403 A KR950700403 A KR 950700403A KR 1019940703107 A KR1019940703107 A KR 1019940703107A KR 19940703107 A KR19940703107 A KR 19940703107A KR 950700403 A KR950700403 A KR 950700403A
- Authority
- KR
- South Korea
- Prior art keywords
- medium
- hematopoietic stem
- cells
- human hematopoietic
- stem cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2303—Interleukin-3 (IL-3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1394—Bone marrow stromal cells; whole marrow
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
사람 조혈 간세포는 장기간 배양중에, 특히 적절한 간질 셀라인과의 공동 배양중에, 특히 백혈병 억제 인자의 존재하에, 조혈 간세포 자체로서 또는 다른 이자와 조합하여 성장할 수 있다. 세포는 생체내 T-세포검정 및 메틸셀룰로오스에서 다른 계통의 콜로니들을 형성하는 능력에 의해 증명되는바, 그것의 기능을 보유하는 것으로 밝혀진다. 세포의 형질전환은 바이러스로 이루어질 수 있으며, 이때 백혈병 억제인자와 임의로 다른 조혈인자의 존재하에 개선된 결과가 얻어진다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (20)
- 사람 조혈 간세포를 최소한 약 10ng/ml 의 백혈병 억에 인자를 포함하는 배지와 최소한 12시간동안 접촉시키는 단계; 그리고 상기 간세포를 상기 간세포의 성장을 지지할 수 있는 배지에서 성장시키는 단계를 포함하는 것을 특징으로 하는, 사람 조혈 간세포를 배양배지에서 성장시키는 방법.
- 제 1 항에 있어서, 상기 백혈병 억제 인자가 약 2 내지 20ng/ml의 양으로 존재하는 것을 특징으로 하는 방법.
- 제 1 항에 있어서, 상기 접촉이 최소한 1ng/ml의 IL-3, IL-6, GM-CSF, 또는 강인자중 하나와 이루어지는 것을 특징으로 하는 방법.
- 제 1 항에 있어서, 상기 성장은 간질 셀라인으로부터 부터의 조건 배지의 존재하에 이루어지는 것을 특징으로 하는 방법.
- 제 4 항에 있어서, 상기 간질 셀라인이 상기 배지에 존재하는 것을 특징으로 하는 방법.
- 사람 조혈 간세포를, 약 2 내지 20ng/ml의 백혈병 억제 인자와 최소한 1ng/ml의 하나의 IL-3, IL-6, GM-CSF 또는 강인자를 포함하는 배지와 최소 12시간 동안 접촉시키는 단계와, 상기 간세포를 상기 간세포의 성장을 지지할 수 있는 배지에서 성장시키는 단계를 포함하는 것을 특징으로 하는 배양배지에서 사람 조혈 간세포를 성장시키는 방법.
- 제 6 항에 있어서, 상기 성장은 간질 셀라인으로 부터의 조건 배지의 존재하에 이루어지는 것을 특징으로 하는 방법.
- 제 7 항에 있어서, 상기 간질 셀라인이 상기 배지에 존재하는 것을 특징으로 하는 방법.
- 제 6 항에 있어서, 상기 백혈병 억제 인자가 상기 성장 지지배지중에서 유지되는 것을 특징으로 하는 방법.
- 실질적으로 전용 세포가 없는 사람 조혈 간세포를, 사람세포에 대해 굴성이고, 사람 조혈 세포에서 전사될 수 있는 관심의 DNA 서열을 포함하는 레트로바이러스 벡터와, 최소한 10ng/ml의 백혈병 억제 인자를 포함하는 배지중에서 상기 바이러스가 상기 간세포에 들어가기에 충분한 시간동안 접촉시키는 것으로 이루어지는, 사람 조혈 간세포를 형질전환하기 위한 방법.
- 제10항에 있어서, 상기 배지가 또한 최소한 1ng/ml의 양으로 최소한 하나의 IL-3, IL-6, GM-CSF 또는 강인자를 포함하는 것을 특징으로 하는 방법.
- 제10항에 있어서, 상기 DNA 서열이 사람 조혈세포에서 전살될 수 있는 유전자인 것을 특징으로 하는 방법.
- 제10항에 있어서, 추가로 배양중에 상기 DNA 서열을 포함하는 사람 조혈 간세포를 간세포의 성장을 지지할 수 있는 배지에서 성장시키는 단계를 포함하는 방법.
- 제13항에 있어서, 상기 성장 지지배지가 간질 셀라인으로 부터의 조건 배지인 것을 특징으로 하는 방법.
- 제14항에 있어서, 상기 간질 셀라인이 상기 배지에 존재하는 것을 특징으로 하는 방법.
- 제15항에 있어서, 상기 백혈병 억제 인자가 상기 성장 지지배지중에서 유지되는 것을 특징으로 하는 방법.
- DNA의 통합의 결과로 관심의 DNA 서열을 포함하는 실질적으로 전용 조혈 세포가 없는 사람 조혈 간세포 조성물.
- 제17항에 있어서, 상기 관심의 DNA 서열이 조혈 세포에서 전사될 수 있는 유전자인 것을 특징으로 하는 사람 조혈 간세포 조성물.
- 제18항에 있어서, 상기 유전자 G418내성 유전자인 것을 특징으로 하는 사람 조혈 간세포 조성물.
- 제17항의 사람 조혈 간세포로 부터 유래되는 사람 조혈 세포.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84678292A | 1992-03-04 | 1992-03-04 | |
US07/846,782 | 1992-03-04 | ||
PCT/US1993/001852 WO1993018137A1 (en) | 1992-03-04 | 1993-03-03 | Culturing of hematopoietic stem cells and their genetic engineering |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950700403A true KR950700403A (ko) | 1995-01-16 |
Family
ID=25298935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940703107A KR950700403A (ko) | 1992-03-04 | 1993-03-03 | 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering) |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0631618A4 (ko) |
JP (1) | JPH07504331A (ko) |
KR (1) | KR950700403A (ko) |
AU (2) | AU680406B2 (ko) |
CA (1) | CA2131368A1 (ko) |
WO (1) | WO1993018137A1 (ko) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399493A (en) * | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5437994A (en) * | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5635386A (en) * | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
US6242417B1 (en) | 1994-03-08 | 2001-06-05 | Somatogen, Inc. | Stabilized compositions containing hemoglobin |
US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
US7083979B1 (en) | 1994-03-25 | 2006-08-01 | Indiana University Foundation | Methods for enhanced retroviral-mediated gene transfer |
AU3635695A (en) * | 1994-09-19 | 1996-04-09 | Board Of Trustees Of The Leland Stanford Junior University | Methods for genetically modifying hematopoietic stem cells |
US5648248A (en) * | 1994-12-30 | 1997-07-15 | Boehringer Ingelheim International Gmbh | Methods for producing differentiated cells from immature hematopoietic cells |
EP0821740A1 (en) * | 1995-04-20 | 1998-02-04 | Chiron Corporation | High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
US5728581A (en) * | 1995-06-07 | 1998-03-17 | Systemix, Inc. | Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
ES2265153T3 (es) * | 1995-09-29 | 2007-02-01 | Indiana University Research And Technology Corporation | Metodos para una transferencia de adn mediada por virus potenciada usando moleculas con dominios de union a virus y celulas. |
US5922597A (en) * | 1995-11-14 | 1999-07-13 | Regents Of The University Of Minnesota | Ex vivo culture of stem cells |
GB9807935D0 (en) | 1998-04-14 | 1998-06-10 | Univ Edinburgh | Lineage specific cells and progenitor cells |
WO1997029183A2 (en) * | 1996-02-08 | 1997-08-14 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for transforming dendritic cells and activating t cells |
US6734014B1 (en) | 1996-02-08 | 2004-05-11 | The United States Of America As Represented By The Department Of Health And Human Services | Methods and compositions for transforming dendritic cells and activating T cells |
US5811297A (en) * | 1996-03-07 | 1998-09-22 | Amba Biosciences, Llc | Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages |
JP3962459B2 (ja) * | 1997-10-28 | 2007-08-22 | 麒麟麦酒株式会社 | 造血幹細胞の分化・増殖調節方法 |
US20020034819A1 (en) | 1998-02-23 | 2002-03-21 | Alan K. Smith | Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses |
CA2338344A1 (en) * | 1998-05-29 | 1999-12-02 | Case Western Reserve University | Hematopoietic progenitor cell gene transduction |
GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
CA2369085A1 (en) * | 1999-05-14 | 2000-11-23 | City Of Hope | Ex vivo expansion of mammalian hematopoietic stem cells |
AU1753101A (en) * | 1999-10-29 | 2001-05-14 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Method of in vitro T cell differentiation of CD34+ progenitor cells |
DE602005002430T2 (de) | 2004-09-30 | 2008-06-19 | Reneuron Ltd., Guildford | Zelllinie |
US20160024473A1 (en) | 2013-03-08 | 2016-01-28 | Cells For Cells | Menstrual stems cells for the efficient support and expansion of cd34+ cd133+ hematopoietic stem cells in vitro |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366888A (en) * | 1990-07-09 | 1994-11-22 | Amrad Corporation Limited | Enhanced maintenance of pregnancy using leukaemia inhibitory factor in embryo culturing |
-
1993
- 1993-03-03 EP EP93907130A patent/EP0631618A4/en not_active Withdrawn
- 1993-03-03 WO PCT/US1993/001852 patent/WO1993018137A1/en not_active Application Discontinuation
- 1993-03-03 JP JP5515827A patent/JPH07504331A/ja active Pending
- 1993-03-03 CA CA002131368A patent/CA2131368A1/en not_active Abandoned
- 1993-03-03 AU AU37839/93A patent/AU680406B2/en not_active Ceased
- 1993-03-03 KR KR1019940703107A patent/KR950700403A/ko not_active Application Discontinuation
-
1997
- 1997-10-31 AU AU43690/97A patent/AU4369097A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU680406B2 (en) | 1997-07-31 |
EP0631618A4 (en) | 1995-09-27 |
CA2131368A1 (en) | 1993-09-16 |
EP0631618A1 (en) | 1995-01-04 |
AU3783993A (en) | 1993-10-05 |
AU4369097A (en) | 1998-02-12 |
WO1993018137A1 (en) | 1993-09-16 |
JPH07504331A (ja) | 1995-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950700403A (ko) | 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering) | |
Fibach et al. | Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes | |
McCormack et al. | Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma. | |
Zandstra et al. | Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells | |
US9080147B2 (en) | Culturing human embryonic stem cells with a noggin to generate cells lacking Pax-6 expression | |
EP2221361A3 (en) | Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium | |
ATE464386T1 (de) | Verfahren zur herstellung sekretierter proteine | |
ATE148502T1 (de) | Verfahren, zubereitungen und anordnungen für zellzucht | |
NZ502712A (en) | Medium and method for long term culturing of avian primordial germ cells (PGC) in a tissue culture comprising growth factors | |
Gardner | The use of tricine buffer in animal tissue cultures | |
ATE314461T1 (de) | Vermehrte und genetisch modifizierte populationen menschlicher hämatopoitischer stammzellen | |
DK0634893T3 (da) | Fremgangsmåde til udvikling af nye plantetyper med nitrogenfikserende kapacitet, selv i bladene | |
FI963373A (fi) | Ruumiin ulkopuolinen soluviljelmä ja transplantaatiopakkauksia | |
CA2090677A1 (en) | Method for culturing t lineage precursor cells | |
ATE416257T1 (de) | Promotoren für wachstums-differenzierungsfaktoren und deren verwendung | |
Colman | Synthesis of RNA in oocytes of Xenopus laevis during culture in vitro | |
Collins et al. | Ex vivo culture systems for hematopoietic cells | |
CA2510596A1 (en) | Dendritic cell line | |
FR2736931B1 (fr) | Sequences regulatrices issues du gene cd4 et a expression specifique dans les lymphocytes t matures | |
AU4075093A (en) | Cellular aggregate stabilized culture and process for the development of embryos from a proembryogenic strain for use in vine regeneration techniques | |
Sato et al. | A correlation between melanogenic functions and transformed phenotypes in cultured B16 mouse melanoma cells | |
GB1374492A (en) | Microbial modification of benzodiazepine compounds | |
Vainstein | Regulation and characterisation of invertase in Aspergillus nidulans. | |
RU2094464C1 (ru) | Способ введения экзогенной днк плазмид в клетки млекопитающих, культивируемые in vitro | |
Kaspi et al. | Growth, subculture and cryopreservation of anchorage-dependent cells: A complete serum-free system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |